CVE-2020-3364: cisco cisco ios xr software Improper Access Control
Vulnerability summary
CVE-2020-3364 is a medium (CVSS 5.3) Improper Access Control vulnerability in cisco cisco ios xr software. EPSS estimates a 0.91% chance of exploitation in the next 30 days, higher than 59.4% of scored vulnerabilities.
Timeline
- 18-06-2020PublishedVulnerability first disclosed.
- 15-11-2024Last modifiedVulnerability information updated.
Description
A vulnerability in the access control list (ACL) functionality of the standby route processor management interface of Cisco IOS XR Software could allow an unauthenticated, remote attacker to reach the configured IP addresses on the standby route processor management Gigabit Ethernet Management interface. The vulnerability is due to a logic error that was introduced in the Cisco IOS XR Software, which prevents the ACL from working when applied against the standby route processor management interface. An attacker could exploit this vulnerability by attempting to access the device through the standby route processor management interface.
CVSS metrics
4 scores · 2 sources · 3 versions- NVDNIST5.3MediumCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
EPSS trend
Probability
0.91%
Chance of exploitation in the next 30 days
Percentile
59%
Versus all other CVEs
30-day change
0.00 pp
From 0.91% on 19-09-2026
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root cause- CWE-284Improper Access ControlThe product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
- CWE-863Incorrect AuthorizationThe product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check.
Affected systems
Cisco2 products
- cisco ios xr softwaren/a
- ios_xr6.7.1 | 7.0.2 | 7.0.11 | 7.0.12 | 7.1.1 | 7.1.15
1 vendor · 2 products
References
1 links- tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-xracl-zbWSWREtVendor AdvisoryX Refsource CISCOMitigation